OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ubiquitin–proteasome system-targeted therapy for uveal melanoma: what is the evidence?
Chenxi Zhao, Chenming Zeng, Ke Wang, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 2, pp. 179-188
Open Access | Times Cited: 14
Chenxi Zhao, Chenming Zeng, Ke Wang, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 2, pp. 179-188
Open Access | Times Cited: 14
Showing 14 citing articles:
Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma
Jian-Lan Liu, Pengpeng Zhang, Fang Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 44
Jian-Lan Liu, Pengpeng Zhang, Fang Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 44
MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly
Yan Zhong, Ting Long, Chuan-Sha Gu, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 12, pp. 3251-3269
Open Access | Times Cited: 64
Yan Zhong, Ting Long, Chuan-Sha Gu, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 12, pp. 3251-3269
Open Access | Times Cited: 64
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Development of new therapeutic options for the treatment of uveal melanoma
Janney Z. Wang, Vivian Lin, Elsa Toumi, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6226-6249
Open Access | Times Cited: 26
Janney Z. Wang, Vivian Lin, Elsa Toumi, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6226-6249
Open Access | Times Cited: 26
Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis
Xue Zhu, Ling Wang, Ke Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 552-568
Closed Access | Times Cited: 3
Xue Zhu, Ling Wang, Ke Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 552-568
Closed Access | Times Cited: 3
Crbn-based molecular Glues: Breakthroughs and perspectives
Juzeng An, Xiaojun Zhang
Bioorganic & Medicinal Chemistry (2024) Vol. 104, pp. 117683-117683
Closed Access | Times Cited: 3
Juzeng An, Xiaojun Zhang
Bioorganic & Medicinal Chemistry (2024) Vol. 104, pp. 117683-117683
Closed Access | Times Cited: 3
Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma
Yaquan Li, Xuemeng Liu, Feihu Zhao, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Yaquan Li, Xuemeng Liu, Feihu Zhao, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma
Jiaheng Xie, Liang Chen, Yuan Cao, et al.
Aging (2023) Vol. 15, Iss. 6, pp. 2082-2096
Open Access | Times Cited: 6
Jiaheng Xie, Liang Chen, Yuan Cao, et al.
Aging (2023) Vol. 15, Iss. 6, pp. 2082-2096
Open Access | Times Cited: 6
UBQLN4 is activated by C/EBPβ and exerts oncogenic effects on colorectal cancer via the Wnt/β-catenin signaling pathway
Xiaolong Tang, Yahang Liang, Guorui Sun, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Xiaolong Tang, Yahang Liang, Guorui Sun, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Research Progress on the Role of Ubiquitination in Eye Diseases
Zhongyu Ma, Jiawen Hao, Zhaohui Yang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1825-1836
Closed Access | Times Cited: 1
Zhongyu Ma, Jiawen Hao, Zhaohui Yang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1825-1836
Closed Access | Times Cited: 1
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma
Wenying Shu, Xue Zhu, Ke Wang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 601-619
Open Access | Times Cited: 7
Wenying Shu, Xue Zhu, Ke Wang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 601-619
Open Access | Times Cited: 7
Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals
Courtney R. Croley, Joshua Pumarol, Blake E. Delgadillo, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108479-108479
Closed Access | Times Cited: 3
Courtney R. Croley, Joshua Pumarol, Blake E. Delgadillo, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108479-108479
Closed Access | Times Cited: 3
UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP
Andi Zhao, Chenyu Zhou, Jin-Jing Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5201-5218
Open Access
Andi Zhao, Chenyu Zhou, Jin-Jing Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5201-5218
Open Access
Uveal Melanoma – a review of treatment methods
Aleksandra Domańska, Daria Piekarz, Natalia Pijas, et al.
OphthaTherapy Therapies in Ophthalmology (2023) Vol. 10, Iss. 4, pp. 245-252
Open Access
Aleksandra Domańska, Daria Piekarz, Natalia Pijas, et al.
OphthaTherapy Therapies in Ophthalmology (2023) Vol. 10, Iss. 4, pp. 245-252
Open Access
